Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Elimination of phenacetin and phenazone by man before and after treatment with phenobarbital

  • 25 Accesses

  • 11 Citations


After the oral administration to volunteers of phenacetin (15 mg/kg) the highest concentration in blood was reached 2 h later. The decline appeared to follow first order kinetics with an apparent biological half-life (t′/2) of 0.8 h. The highest concentration in blood of the unconjugated metabolite, paracetamol, was twice that of phenacetin. About 70 per cent of a dose of phenacetin was excreted as conjugated paracetamol in the urine, and 70 per cent of this compound was eliminated during the first 12 h period. — After daily administration of 1.4, 2.5 and 3.6 mg/kg of Phenobarbital, each dose sequentially for 1 week, the apparent biological half-life of phenacetin and the elimination rates of its metabolites, unconjugated and conjugated paracetamol, remained unchanged. The elimination rate of phenazone (16 mg/kg) was increased by 40 per cent in the same subjects after treatment with phenobarbital. — The blood concentration of phenacetin varied more than 20 times between individuals, although no individual variation was found for the blood levels of unconjugated paracetamol.

This is a preview of subscription content, log in to check access.


  1. 1.

    Brodie, B.B., Axelrod, J.: The estimation of acetanilide and its metabolic products, aniline, N-acetyl-p-aminophenol and p-aminophenol (free and total conjugated) in biological fluids and tissues. J. Pharmacol. exp. Ther.94, 22–28 (1948).

  2. 2.

    ——, Soberman, R., Levy, B.B.: The estimation of antipyrine in biological material. J. biol. Chem.179, 25–29 (1949).

  3. 3.

    —— —— The fate of acetophenetidin (phenacetin) in man and methods for the estimation of acetophenetidin and its metabolites in biological material. J. Pharmacol. exp. Ther.97, 58–67 (1949).

  4. 4.

    —— —— The fate of antipyrine in man. J. Pharmacol. exp. Ther.98, 97–104 (1950).

  5. 5.

    Büch, H., Karachristianidis, G., Pfleger, K., Forth, W., Wörner, D.: Ein Verfahren zur routinemäßigen Bestimmung von Arzneimitteln, insbesondere von Barbituraten, bei Schlafmittelvergiftung. Arch. Toxikol.21, 216–224 (1966).

  6. 6.

    Büch, H., Gerhards, W., Pfleger, K., Rüdiger, W., Rummel, W.: Metabolische Umwandlung von Phenacetin und N-acetyl-p-aminophenol nach Vorbehandlung mit Phenobarbital. Biochem. Pharmacol.16, 1585–1600 (1967).

  7. 7.

    Chen, W., Vrindten, P.A., Dayton, P.G., Burns, J.J.: Accelerated aminopyrine metabilism in human subjects pretreated with phenylbutazone. Life Science2, 35–42 (1962).

  8. 8.

    Conney, A.H.: Pharmacological implications of microsomal enzyme induction. Pharmacol. Rev.19, 317–366 (1967).

  9. 9.

    Dost, F.H.: Grundlagen der Pharmakokinetik. Stuttgart: Thieme 1968.

  10. 10.

    Ganshorn, A., Kurz, H.: Unterschiede zwischen der Proteinbindung Neugeborener und Erwachsener und ihre Bedeutung für die pharmakologische Wirkung. Naunyn-Schmiedebergs Arch. Pharm. exp. Path.260, 117 (1968).

  11. 11.

    Kampffmeyer, H.G.: Failure to detect increased elimination rate of phenacetin in man after treatment with phenobarbital. Klin. Wschr.47, 1237–1238 (1969).

  12. 12.

    —— Die biologische Halbwertzeit von Phenacetin und Phenazon im Menschen vor und nach der Behandlung mit Phenobarbital. Naunyn-Schmiedebergs Arch. Pharmak.266, 367 (1970).

  13. 13.

    Prescott, L.F., Sansur, M., Levin, W., Conney, A.H.: The comparative metabolism of phenacetin and N-acetyl-p-aminophenol in man, with particular reference to effects on the kidney. Clin. pharmacol.Ther.9, 605–614 (1968).

  14. 14.

    —— Metabolism of phenacetin in patients with renal disease. Clin. pharmacol. Ther.10, 383–394 (1969).

  15. 15.

    —— Steel, R.F., Feuries, W.R.: The effects of particle size on the absorption of phenacetin in man. Clin. pharmacol. Ther.11, 496–504 (1970).

  16. 16.

    Welch, R.M., Conney, A.H.: A simple method for the quantitative determination of N-acetyl-p-aminophenol (APAP) in urine. Clin. Chem.11, 1064–1067 (1965).

Download references

Author information

Additional information

Parts of this paper have been published in a short communication [11] and at the 11. Frühjahrstagung der Deutschen Pharmakologischen Gesellschaft on March 15–18, 1970 [12].

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Kampffmeyer, H.G. Elimination of phenacetin and phenazone by man before and after treatment with phenobarbital. Eur J Clin Pharmacol 3, 113–118 (1971). https://doi.org/10.1007/BF00619304

Download citation


  • Enzyme-induction
  • man
  • phenacetin
  • phenazone